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BACKGROUND. Stromal invasion is 1 of the main features used to distinguish
high-grade dysplastic nodules (DNs) from well-differentiated hepatocellular carci-
nomas (HCCs). The authors hypothesized that ductular reaction (DR) takes place
around noninvasive hepatocellular nodules but not within the stroma contiguous
to invasive HCC.
METHODS. DR/cytokeratin 7 (CK7)-positive patterns were evaluated in 105
resected small hepatic nodules according to the level of invasion. The nodules
were classified histologically prior to immunostaining as noninvasive (large re-
generative nodules, low-grade DNs, and high-grade DNs), minimally invasive
(early HCCs with a vaguely nodular type), and overtly invasive (typical HCCs
with a distinctly nodular type) in a review by expert pathologists, the current
gold standard. Intranodular DR (inner DR) and DR around the nodule periphery
(outer DR) were assessed separately on a semiquantitative scale from 0 to 4þ.
RESULTS. DR was 3 or 4þ in the majority of noninvasive nodules (inner DR, 81%;
outer DR, 91%), whereas DR was 0 or 1þ in overtly invasive HCCs (inner DR,
96%; outer DR, 81%). Minimally invasive HCCs showed an intermediate DR pat-
tern (2 or 3þ inner DR, 75%; 2þ outer DR, 67%). DR characteristically was absent
at the stromal-invasive, leading edge of tumor cells in both minimally invasive
HCCs (focal loss of DR/CK7) and overtly invasive HCCs (diffuse loss of DR/CK7).
The DR patterns in 41 needle-biopsy samples were similar to the patterns
observed in resected nodules.
CONCLUSIONS. DR/CK7 immunostaining may help to identify small foci of inva-
sion and to distinguish noninvasive, high-grade DNs from both minimally inva-
sive and overtly invasive HCCs. Cancer 2007;109:915–23.
 2007 American Cancer Society.
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T he histologic details of early-stage human hepatocarcinogenesishave been well documented. Among the lesions that represent
some of these early pathways, dysplastic nodules (DNs), especially
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high-grade DNs, currently are considered premalig-
nant.1–6 Although the first sign of malignancy in
many epithelial malignancies is invasion through a
preexisting basement membrane, this feature does
not apply to hepatocellular lesions given the absence
of a hepatocyte basement membrane. Instead, the
histologic hallmark of transition to malignancy is
now considered stromal invasion, that is, invasion
into the portal tract or septal stroma within a hepa-
tocellular (premalignant) nodule.
However, the identification of stromal invasion
in patients with chronic liver disease, the clinical set-
ting for most of these lesions, may be difficult in
well-differentiated hepatocellular carcinomas (HCCs),
including what Japanese researchers call early HCCs,
because well-differentiated tumor cells show little or
no cytologic atypia, and stromal invasion often is
focal.1,4,7,8 It is still more difficult when dealing with
biopsied liver tissue, in which only limited portions
of nodules are sampled. The differential diagnosis of
such lesions would be hepatocytes surrounded by
scar in the setting of chronic liver disease. Such small
clusters of scar-enveloped hepatocytes have been
referred to as hepatocyte buds.9
With 3-dimensional reconstructions, it has been
demonstrated that these intraseptal hepatocyte buds are
contiguous with ductular reactions (DRs) that are indic-
ative of regeneration from intrabiliary progenitors.10,11
Thus, stromal invasion by early, well-differentiated HCC,
although it shares a superficial appearance with intra-
septal hepatocyte buds, may differ, because the latter
generally is accompanied by this histologic feature of
progenitor cell activation and hepatobiliary differentia-
tion (ie, DR). We hypothesize that such regenerative DR,
highlighted by routine immunohistochemistry for bili-
ary-type cytokeratin (CK7), is found around noninvasive
hepatocellular nodules but not within the desmoplastic
stroma contiguous to invasive HCC. The objectives of
the current study were to test this hypothesis and to
document whether the DR pattern, identified by CK7
immunostaining in surgical resections and biopsies of
hepatocellular nodules, can help to highlight the pre-
sence of stromal invasion and, thereby, to identify well-
differentiated HCC in nodular hepatocellular lesions
from patients with chronic liver disease.
MATERIALS AND METHODS
Material and Pathologic Examination
Small hepatocellular nodules (2 cm) that were diag-
nosed as large regenerative nodules (LRNs), DNs, or
HCCs were selected from archival files of patients
resection and the specimens were supported by the
Liver Cancer Specimen Bank from the National
Research Resource Bank Program of the Korea
Science & Engineering Foundation in the Ministry of
Science & Technology. Biopsied cases of small he-
patic nodules also were collected.
The diagnosis of each hepatic nodule was made
according to the criteria of the International Working
Party as follows: 1) LRN, 2) low-grade DN, 3) high-grade
DN, or 4) HCC.12 LRN is a multiacinar, regenerative
nodule that is distinctly larger than most cirrhotic
nodules of the same liver, generally0.5 cm in greatest
dimension. DN is a nodular region of hepatocytes with
dysplasia but without definite histologic criteria of
malignancy; low-grade DN shows mild atypia, and
high-grade DN shows at least moderate atypia. Low-
grade DNs are differentiated from LRNs by features
of large liver cell change, minimal nuclear abnormal-
ities, and clone-like changes that are not detected
in LRNs, such as diffuse hemosiderosis (in the absence
of further distinguishing nodule-in-nodule lesions).
High-grade DNs are characterized by 1) increased cel-
lularity with a nuclear/cytoplasmic ratio 1.5 to 2 times
more than that of adjacent cirrhotic nodules, 2) focal
acinar arrangement, and 3) nodule-in-nodule lesions.
Well-differentiated HCCs show increased cellularity
and a nuclear/cytoplasmic ratio more than twice that
of adjacent cirrhotic nodules and frequent acinar
arrangement.3,4,6,12,13
Small HCCs (2 cm) were subcategorized further
into HCCs of vaguely nodular type and HCCs with dis-
tinctly nodular type based on macroscopic fea-
tures.1,4,13,14 The vaguely (indistinctly) nodular type
retains the basic architecture of the background cirrho-
tic liver in varying degrees, and the cancer cells grow in
a replacing trabecular pattern at the tumor/nontumor
boundaries as though they were replacing the non-
neoplastic liver cords. Thus, the tumor boundary is ill
defined without tumor capsule. Histologically, most
tumors of this type are well-differentiated HCCs with
little cellular or architectural atypia and with a varying
combination of the following features; 1) increased cel-
lularity with increased nuclear/cytoplasmic ratio and
2) an irregular, thin, trabecular pattern 2 to 3 cells thick
with frequent acinar arrangement and frequent fatty
changes. Small HCC of the vaguely nodular type is con-
sidered as an early lesion and is designated as early
HCC by Japanese researchers.1,4,13,14 In contrast, small
HCC of the distinctly nodular type is well demarcated,
frequently encapsulated, and usually shows typical
HCC histologic features. Therefore, biologically, it is
considered a further step, compared with early HCC,
on the route of cancer progression despite its small
size.
The paraffin-embedded tissue from each nodule
was sectioned serially and stained with hematoxylin
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and eosin (H&E). The categorical diagnostic assign-
ments for each of the hepatic nodules in this study
were arrived at by consensus between 2 or 3 of the
participating pathologists and discussions over a
multiheaded microscope. The diagnoses were based
on H&E features and, when necessary, by additional
CD34 immunostaining to highlight sinusoidal capil-
larization, which generally was focal in high-grade
DNs and diffuse in well-differentiated HCCs.15–17
Evaluation of DR
Immunohistochemical staining for CK7 (monoclonal;
DAKO, Carpenteria, CA; dilution, 1:100) was performed
by using an LSAB kit (DAKO) as described previously.18
CK7-immunoreactive DRs were analyzed at the epithe-
lial-stromal boundaries within and at the outer edge of
each nodule. The intranodular (inner) DR was semi-
quantified as follows: 0 ¼ none, 1 ¼ <10%, 2 ¼ 10% to
25%, 3 ¼ 26% to 50%, and 4 ¼ >50% of the epithelial-
stromal interface involved by DR/CK7. The peripheral
(outer) DR between the lesional nodule and the sur-
rounding liver tissue was scored similarly: 0 ¼ none,
1 ¼ <10%, 2 ¼ 10% to 25%, 3 ¼ 26% to 50%, and
4 ¼ >50% of the nodular circumference involved by
DR/CK7. The differences in the extent of DR among the
categories of hepatocellular nodules were evaluated sta-
tistically by using the Fisher exact test.
RESULTS
DR in Resected Hepatic Nodules
The pathologic diagnoses of the 105 resected hepatic
nodules that were included in this study were LRN
(n ¼ 10 nodules), low-grade DN (n ¼ 28 nodules), high-
grade DN (n ¼ 29 nodules), small HCC of the vaguely
nodular type (n ¼ 12 nodules), and small HCC of the
distinctly nodular type (n ¼ 26 nodules). The relevant
clinicopathologic information is summarized in Table 1.
Morphologically identifiable stromal invasion
was not observed in nonmalignant hepatocellular
nodules (LRN, low-grade DN, and high-grade DN)
but only in histologically defined HCC. In well-differ-
entiated HCC of the vaguely nodular type, stromal
invasion was focal and subtle. It also may have been
present in some entrapped intralesional portal tracts,
suggesting a minimally invasive type of HCC. In HCC
of the distinctly nodular type, stromal invasion was
more frequent and obvious, indicating a more overtly
invasive phenotype of HCC.
DRs were positive uniformly and strongly for
CK7. Intraseptal hepatocytes and noninvasive hepato-
cyte-stromal boundaries revealed CK7-positive DR
(Fig. 1). In contrast, HCC cells that invaded entrapped
intralesional portal tracts and fibrous stroma within
HCC showed no CK7-positive DR (Fig. 2).
Inner DR results are summarized in Table 2.
Inner DR was florid (3þ or 4þ) in 54 of 67 of nonin-
vasive type nodules (81%), including LRNs, low-grade
DNs, and high-grade DNs. In contrast, overtly inva-
sive HCCs of the distinctly nodular type showed little
or negative inner DR (0 or 1þ) in 25 of 26 samples
(96%). Therefore, the inner DR pattern differed sig-
nificantly between noninvasive hepatic nodules and
invasive HCCs (P < .001). In well-differentiated HCCs
of the vaguely nodular type that showed a doubtful,
minimally invasive phenotype on H&E examination,
inner DR was 2 or 3þ in 9 of 12 samples (75%). The
invasive foci were distributed focally and, overall, a
retained CK7-positive DR was observed at the epithe-
lial-stromal interface. However, the extent of DR in
vaguely nodular DN was significantly higher than
that detectable in the overtly invasive HCCs (small
HCCs of the distinctly nodular type), which showed
little or no DR in most samples (25 of 26 nodules;
96%; P < .001). The inner DR pattern of minimally
invasive HCCs overlapped to some extent with the
pattern observed in noninvasive type nodules, which
showed 2 or 3þ DR in the majority of samples (44 of
67 nodules; 66%). The focal but unequivocal loss of
CK7-positive DR at the leading edge of HCC with
stromal invasion helped to distinguish minimally
invasive HCCs of the vaguely nodular type from all
nonmalignant hepatocellular nodules (Fig. 3).
Outer DR findings are summarized in Table 3.
The degree of outer DR differed significantly (P
< .001) between nodules according to the presence
or absence of stromal invasion. All noninvasive
nodules, including LRNs, low-grade DNs, and high-
grade DNs, showed florid outer DR; 4þ outer DR was
observed in 10 of 10 LRNS (100%), in 15 of 28 low-
grade DNs (54%), and in 16 of 29 high-grade DNs
(55%) (Fig. 1). In contrast, outer DR was absent or
scant (0 or 1þ) in 21 of 26 HCCs of the distinctly
nodular type (81%), in 13 of 26 HCCs (50%) showed
no outer DR, and 8 of 26 HCCs (31%) showed 1þ
outer DR (Fig. 2); whereas 5 of 15 moderately differ-
entiated HCCs of the distinctly nodular type (33%)
showed 2þ or 3þ outer DR. This may be considered
a noninvasive region of HCC with invasion elsewhere
or, alternatively, non-neoplastic residual-entrapped
portal tracts at the edge of invasive tumor. In these
tumors, the identification of stromal invasion was
not problematic because of more obvious histologic
and cytologic atypia. Well-differentiated HCCs of the
vaguely nodular type with minimal invasion showed
2þ outer DR in most samples (8 of 12 nodules; 67%);
however, in 1 nodule (8%) that showed focal stromal
invasion within the nodule, 4þ florid outer DR was
observed (Fig. 3).
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DR in Biopsied Hepatic Nodules
The morphologic diagnoses of the 41 needle-biopsied
samples of small hepatocellular nodules that we
studied were LRNs (n ¼ 7 nodules), low-grade DNs
(n ¼ 4 nodules), high-grade DNs (n ¼ 5 nodules),
and well-differentiated HCCs (n ¼ 21 nodules). There
were 4 borderline results in which the distinction
between high-grade DN and HCC was uncertain with
TABLE 1
Clinicopathologic Data on Resected Hepatic Nodules
Lesion
Mean age
(Range), y Sex (M:W)
Mean lesion size
(Range), cm
Etiology, No. of patients
No. with cirrhosis [%]*HBV HCV Alc Biliary
LRN, n ¼ 10 54.8 (43–62) 8:2 0.6 (0.5–1.3) 9 0 1 0 10 [100]
LGDN, n ¼ 28 55.2 (44–72) 20:8 1.0 (0.5–1.5) 25 2 0 1 26 [93]
HGDN, n ¼ 29 55.5 (44–68) 20:9 1.2 (0.6–1.9) 25 4 0 0 29 [100]
Small HCC, vaguely nodular type, WD, n ¼ 12 63.4 (51–80) 7:5 1.2 (0.7–1.8) 6 5 0 1 12 [100]
Small HCC, distinctly nodular type, n ¼ 26 52.6 (43–71) 18:8 1.5 (0.7–2.1) 15 10 1 0 24 [92]
Small HCC, distinctly nodular type, WD, n ¼ 11 56.4 (43–71) 7:4 1.4 (0.7–2.1) 5 6 0 0 10 [91]
Small HCC, distinctly nodular type, MD, n ¼ 15 55.1(43–64) 11:4 1.5 (1.0–2.0) 10 4 1 0 14 [93]
M:W indicates the ratio of men to women; HBV, hepatitis B virus; HCV, hepatitis C virus; Alc, alcoholic; LRN, large regenerative nodule; LGDN, low-grade dysplastic nodule; HGDN, high-grade dysplastic nodule;
HCC, hepatocellular carcinoma; WD, well differentiated; MD, moderately differentiated.
* Cirrhosis in the background liver.
FIGURE 1. Ductular reaction (DR) patterns of dysplastic nodules. Intraseptal hepatocytes at the epithelial-stromal border showing cytokeratin 7 (CK7)-positive
DR, indicating a noninvasive pattern. (a-d) A low-grade dysplastic nodule with inner DR within the nodule and with outer DR between the nodule and non-nodu-
lar areas. (e-h) A high-grade dysplastic nodule with inner DR within the nodule (e,f) and with outer DR between the nodule and non-nodular areas (g,h). DR is
florid around cirrhotic nodules (arrows in d,h) (hematoxylin and eosin, immunohistochemical stain for CK7).
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the needle-core sampling. The clinicopathologic fea-
tures are summarized in Table 4.
It was not possible to assess inner DR and outer
DR separately in the biopsied nodules because of the
lack of a clear nodular topography in most of the
small liver fragments. DR generally was semiquanti-
fied at the epithelial-stromal interface, and the find-
ings are summarized in Table 5. The degree of DR
differed significantly between clearly invasive and
noninvasive lesions (P < .001).
All noninvasive hepatocellular nodules (LRNs,
low-grade DNs, and high-grade DNs) showed florid
DR at the epithelial-stromal boundaries (4þ DR in 7
of 16 nodules [44%] and 3þ in 6 of 16 nodules
[38%]), and there were no DR-negative or 1þ DR
nodules. Sixteen of 21 HCCs (76%) showed no DR, in
keeping with an overtly invasive phenotype; whereas
5 of 21 HCCs (24%) showed residual DR and had
morphology consistent with a minimally invasive
FIGURE 2. Ductular reaction (DR) patterns of overtly invasive hepatocellular carcinoma (HCC). (a-d) Inner DR is absent in areas of stromal invasion (a,b) and
portal tract invasion (c,d, arrows). The bile duct is positive for cytokeratin-7 (CK7). (e,f) The outer border of the lesion (arrows) shows no CK7-positive DR, indi-
cating an overtly invasive HCC phenotype. (g,h) Rare, overtly invasive type HCC shows focal (2þ) outer DR (arrows), which may be a noninvasive component of
the invasive HCC or residual-entrapped portal tracts within the invasive tumor (hematoxylin and eosin, immunohistochemical stain for CK7).
TABLE 2
Inner Ductular Reaction at Intralesional Epithelial-Stromal Interface
Lesion
Degree of inner ductular
reaction
0 1þ 2þ 3þ 4þ
LRN, n ¼ 10 0 0 1 2 7
LGDN, n ¼ 28 0 0 4 15 9
HGDN, n ¼ 29 0 2 6 16 5
Small HCC, vaguely nodular type, WD, n ¼ 12 0 3 5 4 0
Small HCC, distinctly nodular type, n ¼ 26 15 10 1 0 0
Small HCC, distinctly nodular type, WD, n ¼ 11 8 3 0 0 0
Small HCC, distinctly nodular type, MD, n ¼ 15 7 7 1 0 0
LRN indicates large regenerative nodule; LGDN, low-grade dysplastic nodule; HGDN, high-grade dys-
plastic nodule; HCC, hepatocellular carcinoma; WD, well differentiated; MD, moderately differen-
tiated.
* The degree of inner ductular reaction was scored as the percentage of the epithelial-stromal inter-
face involved by cytokeratin 7/ductular reaction as follows: 0 ¼ none, 1 ¼ <10%, 2 ¼ 10%–25%,
3 ¼ 26%–50%, and 4 ¼ >50%.
Ductular Reaction in Hepatic Nodules/Park et al. 919
phenotype of HCC, with partly invasive (DR-nega-
tive) and partly noninvasive (DR-positive) areas in
the same biopsy (Fig. 4). In 2 of 4 borderline nodules
(DN/HCC), DR-negative/DR1þ areas were observed
focally. The other 2 borderline lesions showed DR-
positive areas (DR2þ or 3þ).
DISCUSSION
Stromal invasion has been proposed as an important
diagnostic feature of HCC, although its appearance, par-
ticularly for the inexperienced liver pathologist without
extensive exposure to resected hepatocellular nodules or
explanted cirrhotic livers, can be similar to regenerative
intraseptal hepatocyte buds. It was demonstrated pre-
viously that these non-neoplastic, intraseptal hepato-
cytes are associated with DR in chronic liver diseases.10
Because the most proximal branches of the biliary tree
(ie, the canals of Hering and ductules) comprise or at
least harbor facultative hepatic stem cells,10,11 using the
terminology of Wanless et al.,9 these intraseptal hepato-
FIGURE 3. Ductular reaction (DR) patterns in minimally invasive hepatocellular carcinoma (HCC) of the vaguely nodular type (early HCC). (a-d) The intranodu-
lar, invasive, leading edge of the tumor is indicated by arrowheads. Inner cytokeratin 7 (CK7)-positive DR is not present apart from some residual CK7-positive
DR in the entrapped portal tract. (e-h) Outer CK7/DR is scanty (arrows) between the lesion and the adjacent liver tissue in contrast to CK7-positive DR of the
cirrhotic nodules around the lesion (hematoxylin and eosin, immunohistochemical stain for CK7).
TABLE 3
Outer Ductular Reaction at the Fibrous Border between Nodular
Lesion and Nonlesional Liver Tissue
Lesion
Degree of outer ductular
reaction*
0 1þ 2þ 3þ 4þ
LRN, n ¼ 10 0 0 0 0 10
LGDN, n ¼ 28 0 0 4 9 15
HGDN, n ¼ 29 0 1 1 11 16
Small HCC, vaguely nodular type, WD, n ¼ 12 0 1 8 2 1y
Small HCC, distinctly nodular type, n ¼ 26 13 8 2 3 0
Small HCC, distinctly nodular type, WD, n ¼ 11 8 3 0 0 0
Small HCC, distinctly nodular type, MD, n ¼ 15 5 5 2 3 0
LRN indicates large regenerative nodule; LGDN, low-grade dysplastic nodule; HGDN, high-grade dys-
plastic nodule; HCC, hepatocellular carcinoma; WD, well differentiated; MD, moderately differen-
tiated.
* The degree of outer ductular reaction was scored as the percentage of nodular circumference
involved by cytokeratin 7/ductular reaction as follows: 0 ¼ none, 1 ¼ <10%, 2 ¼ 10%–25%, 3 ¼ 26%–
50%, and 4 ¼ >50%.
y This sample showed focal stromal invasion (negative ductular reaction area) within the nodule.
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cytes probably represent buds of newly formed hepato-
cytes arising from branches of the biliary tree.
Based on this understanding, we hypothesized
that, although DR is observed around noninvasive
(benign) hepatocellular nodules, it would not be
present within the preexisting portal/septal stroma
or the reactive desmoplastic stroma invaded by HCC.
The results from the current study confirmed that
noninvasive hepatocellular-stromal boundaries were
associated with CK7-positive DRs, whereas the areas
of morphologically identified stromal invasion did
not show CK7-positive DR. Inner DR and outer DR
were obvious and florid (4þ) in the majority of non-
invasive nodules, such as LRNs, low-grade DNs, and
high-grade DNs. In contrast, inner DR and outer DR
were scant or absent (1þ or 0) in most HCCs of the
distinctly nodular type, showing an overtly invasive
phenotype. With regard to well-differentiated HCCs
of the so-called vaguely nodular type (early HCC),
which showed the minimally invasive phenotype, the
degrees of inner DR and outer DR were intermediate
between those observed in noninvasive hepatic
nodules and overtly invasive HCCs. CK7 DR usually
was absent in the small foci of invasive tumor in
minimally invasive HCCs, which distinguished it
from both dysplastic nodules (without focal DR loss)
and overtly invasive HCCs (with diffuse DR loss).
Most malignant and nonmalignant nodules con-
tained some residual DR. DR scores of 2þ and 3þ
were most prevalent in noninvasive nodules and also
were observed in minimally invasive HCCs, in which
DR was observed around potentially premalignant
regions. Focal DR also could be seen rarely in overtly
invasive HCC, which emphasizes the concept that the
DR-negative focus is the salient feature that supports
an interpretation of stromal invasion, rather than reli-
ance on the DR semiquantification that was used in
the current study for the purpose of data analysis.
Small HCCs (2cm) can be subclassified into
HCCs of a vaguely nodular type (so called early
HCCs) and HCCs of a distinctly nodular type. Tumor
cell invasion into the portal vein and minute intrahe-
patic metastases in the proximity of the tumor are
observed in 27% and 10% of distinctly nodular HCCs,
respectively, but are not observed in vaguely nodular
HCCs.1,4 Therefore, vaguely nodular HCCs likely cor-
respond to carcinoma in situ and minimally invasive
(or microinvasive) carcinoma of other organs; in con-
trast, distinctly nodular HCCs are biologically more
advanced HCCs despite their small size. The identifi-
cation of early HCCs is important for more effective
radical surgical (or ablation) therapy.
Stromal invasion, which is an objective criterion
of carcinoma, can be identified with relative ease in
most HCCs of the distinctly nodular type (typical
HCCs). However, stromal invasion is obscure in well-
differentiated HCCs of the vaguely nodular type
(early HCCs), because any such invasion is focal, of-
ten minimal, and has little cytologic or structural
TABLE 4
Clinicopathologic Data on Hepatic Nodular Lesions With Biopsy Samples
Lesion Mean age (Range), years Sex (M:W)
Etiology
HBV HCV Alcoholic Cryptogenetic Dysmetabolic Unknown
LRN (n ¼ 7) 65.7 (60–71) 6:1 0 6 0 0 0 1
LGDN (n ¼ 4) 65.5 (58–77) 3:1 1 1 2 0 0 0
HGDN (n ¼ 5) 59.6 (41–72) 4:1 0 2 1 0 0 2
Borderline lesions (n ¼ 4) 60 (51–65) 3:1 2 1 0 1 0 0
HCC (n ¼ 21) 78 (58–79) 17:4 5 7 0 0 4 5
M:W indicates the ratio of men to women; HBV, hepatitis B virus; HCV, hepatitis C virus; LRN, large regenerative nodule; LGDN, low-grade dysplastic nodule; HGDN, high-grade dysplastic nodule; HCC, hepato-
cellular carcinoma.
TABLE 5
Ductular Reaction at the Fibrous Border Between Nodule
and Nonnodule in Biopsy Samples
Lesion
Degree of ductular reaction*
0 1þ 2þ 3þ 4þ
LRN (n ¼ 7) 0 0 2 2 3
LGDN (n ¼ 4) 0 0 0 2 2
HGDN (n ¼ 5) 0 0 1 2 2
Borderline lesions (n ¼ 4) 0 2 1 1 0
HCC (n ¼ 21) 16 4 1 0 0
LRN indicates large regenerative nodule; LGDN, low-grade dysplastic nodule; HGDN, high-grade dys-
plastic nodule; HCC, hepatocellular carcinoma.
* The degree of ductular reaction was scored as the percentage of epithelial-stromal interface
involved by cytokeratin 7/ductular reaction as follows: 0 ¼ none, 1 ¼ <10%, 2 ¼ 10%–25%, 3 ¼ 26%–
50%, and 4 ¼ >50%.
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atypia. The identification of stromal invasion is parti-
cularly difficult in liver biopsy samples.7,8 Although
the pathologists who contributed to this study are
recognized experts in this diagnostic area, and,
indeed, such expert review is considered the gold
standard of diagnosis, this standard is of limited
practicality, because the majority of liver pathologists
lack the opportunity to examine resected nodules or
cirrhotic explants consistently for the development of
such expertise. Therefore, the recognition of subtle
lesions of stromal invasion can be difficult. Our find-
ing of the absence of CK7-positive DRs in foci of
expert-recognized stromal invasion suggests that im-
munostaining for these structures may be a useful
adjunct for this diagnostic dilemma and may help to
sensitize pathologists to the appearance of the histo-
logic lesion. Recently, several novel immunohisto-
chemical and molecular markers of hepatocellular
malignancy have been proposed, including glypican
3,19 heat-shock protein 70,20 glutamine synthetase,21
and human telomerase reverse transcriptase.22 Be-
cause CK immunostaining cannot address, per se, all
of the problematic cases, we suggest that this anti-
body probably is most informative if it is used within
a panel of markers of hepatocellular malignancy.
In conclusion, the current results demonstrate
that expert-identified stromal invasion, even of well-
differentiated HCC, is devoid of CK7-positive DR. DR
remains a sign of newly regenerating hepatocytes in
chronic liver disease and, thus, does not also develop
either from biliary metaplasia of malignant hepato-
cytes or from the outgrowth of biliary cells to contact
these invading cancer cells. The finding that many of
these well-differentiated HCCs are not overtly chole-
static suggests that bile excretion is maintained
through canalicular links between malignant and
neighboring benign hepatocytes, either by loss of the
bile-producing metabolic pathways in the malignant
cells or by retrograde, basilar excretion of bile in ma-
lignant hepatocytes.
FIGURE 4. Ductular reaction (DR) patterns in biopsy samples from hepatocellular nodular lesions. (a,b) A high-grade dysplastic nodule with florid peripheral
DR indicates a noninvasive (DR-positive) lesion. (c,d) Hepatocellular carcinoma shows no DR at the epithelial-stromal interface, indicating an invasive (DR-nega-
tive) phenotype. (e-h) Biopsied hepatic nodule with morphologic atypia and both DR-positive areas (e,f) and DR-negative areas (g,h) at the epithelial-stromal
interface in the same biopsy, suggesting a minimally invasive phenotype (mixed DR-positive/DR-negative). Cytokeratin 7 (CK7)-positive immunoreactive struc-
tures (arrows in h) are preexisting bile ducts entrapped within the lesion (hematoxylin and eosin, immunohistochemical stain for CK7).
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We also believe that the absence of CK7-positive
DR is a useful marker for characterizing areas of
stromal invasion in small HCC and, thus, for distin-
guishing noninvasive hepatocellular lesions (DNs),
minimally invasive HCC of the vaguely nodular type
(early HCCs), and overtly invasive HCCs of the nodu-
lar type (typical/classic HCC with stromal invasion).
In the setting of cirrhosis, these hepatocellular
nodules pose an increasingly frequent differential
diagnostic problem, although few pathologists have
had consistent experience with them. Thus, we sug-
gest that the assessment of CK7-positive DRs may
improve diagnostic confidence in both needle-biopsy
specimens and resection specimens for nonexpert
pathologists who are faced with the spectrum of
lesions that occurs in small hepatocellular nodules.
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